Evidence map›Paper›PMID 42903560›Full record

ArticlehLife2026

Migrasome-driven mitocytosis relieves mitochondrial damage induced by chikungunya virus TF and 6K.

Shengnan Wang, Dan Zhang, Leiliang Zhang

Abstract read
In one paragraph

Article in hLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shengnan WangDepartment of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong, China.
Dan ZhangDepartment of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong, China.
Leiliang ZhangDepartment of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) infection induces the formation of migrasomes, yet their specific role in CHIKV pathogenesis remains unclear. This study explores the mechanisms underlying mitochondrial damage induced by CHIKV 181 clone 25 (CHIKV 181/25) and the role of migrasomes in mitigating this damage. Using cultured cell lines, we assessed the impact of CHIKV infection on mitochondrial integrity and function, with particular emphasis on the viroporin proteins transframe (TF) and 6K. We utilized fluorescence microscopy and transmission electron microscopy to visualize the interplay between migrasome formation and damaged mitochondria. Additionally, calcium imaging assays were conducted to evaluate intracellular calcium levels, and RNA sequencing was performed to examine gene expression. Our results demonstrated that CHIKV infection leads to mitochondrial damage, mediated by the action of TF and 6K. Notably, migrasomes induced by nonstructural protein 1 (nsP1) effectively clearing impaired mitochondria through mitocytosis. Furthermore, we identified the arginine residue R37 within the viroporin proteins of CHIKV as crucial for inducing mitochondrial damage through elevated intracellular calcium levels. Importantly, R37 within TF from other alphaviruses is also critical for mitochondrial damage. In conclusion, our findings elucidate the complex interplay between CHIKV and mitochondrial dysfunction, positioning migrasomes as potential mediators in alleviating CHIKV-induced mitochondrial damage.

Indexed as

6Kchikungunya virusmigrasomemitochondrial damagetransframe (TF)

Identifiers

PMID42903560
PMCPMC13681651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.